US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 1.105
  • +0.085+8.33%
Trading Aug 12 14:43 ET
230.08MMarket Cap-800P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sangamo Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 6, 2024

Revenue(YoY)

356.00K

-94.79%
EPS(YoY)

-0.18

+72.73%
Analyst Rating

Buy

Aug 7, 2024

Sangamo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.817M--
--2024/Q3-- / 25.100M--
Aug 6, 20242024/Q2356.000K / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--
--2023/Q42.042M / 8.105M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.817M--
--2024/Q3-- / 25.100M--
Aug 6, 20242024/Q2356.000K / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--
--2023/Q42.042M / 8.105M--

Unlock Free Earnings Estimates

Sangamo Therapeutics Earnings Reports

  • Sangamo Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:07 ET

  • Sangamo Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 16:10 ET

  • Sangamo Therapeutics | 10-K: FY2023 Annual Report

    Mar 13 07:53 ET

  • Sangamo Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 1, 2023 16:17 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 7, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Gene Editing
    Gene Editing
    Intraday-1.23%
    Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-1.70%